The data indicated that there was no significant difference in the mRNA levels between normal and lung cancer patients, implying that other mechanism(s), such as protein stability or translational activity, might be crucial for the regulation of Sp1 during lung cancer progression. This evidence concerns the gene SP1 and lung cancer.